Analyst Ratings for 4D Molecular Therapeutics (FDMT)
FDMT Rating Summary
FDMT Price Target Summary
- Highest: $37.00 (B.Riley)
- Lowest: $17.00 (Leerink)
- Average: $29.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.56 (+106%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
Avg. $ Target:
$29.56 (+106%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/31/2026 | B.Riley | Mayank Mamtani | New Coverage | Buy (N/A) |
37.00 (N/A) |
9.61 (14.35) |
49.32% | Details |
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
33.00 (N/A) |
7.97 (14.35) |
80.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
